Original price was: £295.00.£236.00Current price is: £236.00.
1-day live online training
Understand the what, the why and the how with term sheets during licensing deals to help your future negotiations
There are limited spaces for this session. If demand is high you may not be able to attend the live session, however you will be sent the recording.
Learn more and register below (click the button).
Discount has been applied to the price above. VAT, if applicable, will be added.
Term Sheets are often touted in press releases and company presentations, yet their nature remains a mystery for some. What exactly is a Term Sheet? What is it for? And what does a “signed” Term Sheet actually mean?
This 2-hour course will provide a comprehensive overview of term sheets when negotiating a licensing agreement. Once completed you will have greater confidence during future licensing negotiations.
This short live online course is part of Educo Life Sciences Pharmaceutical Business Development and Licensing series (BD&L Series). You can view all our business development and licensing courses here. Learn more about how we deliver live online training.
Find out when this course is running so you can plan your training.
2-Hour Course Delivered Over 1-Day
Register at the top of the page.
2-Hour Course Delivered Over 1-Day
Learn more about the course by toggling through the tabs below (trainer, who should attend?)
Course Information
Sign up
10 September 2024 | 45 mins | 1:00 PM UK
A Guide to Business Development and Partnering Events
1 November 2024
120 mins | 1:00 PM UK
Overview of Term Sheets
Special Situations and Clauses
Dr Carlos Velez is the Founder and Managing Partner of Lacerta Bio, an international consultancy specializing in both in- and out-licensing of prescription and non-prescription product candidates and commercial products, across multiple therapeutic areas and markets. He also has extensive experience in business development and licensing, such as valuation, portfolio analysis and prioritization, and business planning. He has presented courses in business development and licensing at partnering events, and customized training programs for clients in Europe and Asia.
Carlos is also the co-founder of Connexin Therapeutics, a company currently raising it second round of financing for the development of retinal neuroprotectants. Prior to the formation of Lacerta Bio in 2010, he was the Director of Business Development at Penwest Pharmaceuticals, where he was responsible for the out-licensing of internally-developed 505(b)(2) programs, as well as the scouting and analysis of in-licensing opportunities in neurology. Penwest was acquired by Endo Pharmaceuticals in 2010. He was also the Chief Business Officer of Lantic Therapeutics (UK) until 2012. Other previous employers include Forest Labs, Frankel Group (now Huron Consulting) and Genencor (now Danisco).
Carlos holds a B.S. in Pharmacy from the Albany College of Pharmacy, a Ph.D. in Pharmacy from the University of North Carolina at Chapel Hill, and an MBA in Technology Management from the Rochester Institute of Technology.
This course is aimed at professionals who are involved in pharmaceutical business development & licensing. The course will appeal to executives working on either out-licensing or in-licensing projects. Those who will find the course useful include:
Want to train your team, department or whole organisation? This course can be developed into on-demand e-learning and hosted by Educo Life Sciences or on your own LMS platform.
Email [email protected] for more information.
We can customise this course to meet the requirements of your organisation, delivered as a classroom and/or online course.
For more information you can email us at [email protected] or call +44 (0) 203 111 7357.
Complete our contact form by following the link. Get in touch.
| * | • This course is delivered online |
|---|
Educo Life Sciences –
This is a new course – Reviews will be added after the first delivery!